Riskpilot← Back to searchSign inGet full accessNordic LexClinic AB
ABActiveOrg 5591558837Landskronavägen 671Legal activities · NACE 6910Est. 20181 employees
Revenue 2025
SEK 0
EBITDA margin
—
+98% vs 2024
Equity ratio
96.3%
Financial strength
Net profit 2025
SEK -1K
+98% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +98% |
| Net profit | SEK -1K | +98% |
| Total assets | SEK 27K | -4% |
| Equity | SEK 26K | +0% |
| Employees | 1 | — |
Legal name
Nordic LexClinic AB
Org number
5591558837
Legal form
Aktiebolag
NACE code
6910 · Legal activities
Founded
16 april 2018
Share capital
SEK 52 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska erbjuda tjänster inom företagsutveckling, humanjuridik, tvistelösning och avtalsskrivning. Verksamheten omfattar juridisk rådgivning, avtals hantering samt medling i tvister. Bolaget ska även bedriva utbildningsverksamhet genom att förbereda och hålla seminarier, föredrag och kurser. Därutöver får bolaget bedriva därmed förenlig verksamhet.
Address
Landskronavägen 671
Email
abdulwahab.alrifai@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 160 | 72 | 153 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 152 | 37 | −45 | −56 | −1 |
| Depreciation & amort. | −0 | −10 | −10 | −0 | −0 |
| EBIT | 152 | 27 | −55 | −56 | −1 |
| Net financials | — | — | — | −2 | — |
| Profit before tax | 151 | 26 | −55 | −58 | −1 |
| Tax | −32 | −6 | −0 | −0 | −0 |
| Net profit | 119 | 20 | −55 | −58 | −1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 159 | 211 | 91 | 28 | 27 |
| Equity | 154 | 175 | 51 | 26 | 26 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 36 | 40 | 2 | 1 |
| Total debt | 5 | 36 | 40 | 2 | 1 |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20212025
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
-3.8%
This company
18.4%
Market median
-121% vs market
20212025
Net profit margin
-100000.0%
This company
8.1%
Market median
-1234668% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordic LexClinic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Omar Al Smail | Deputy Board Member | 0 companies |
| Abdul Wahab Alrifai | Board of Directors | 0 companies |
| Batoul Alalwani | Deputy Board Member | 0 companies |
| Fouad Mohammad Saleh Hasan Esmail Mesri | Deputy Board Member | 0 companies |